Cambridge Investment Research Advisors, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 1419186
FAIRFIELD, IA
Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$18,208,626
-$1,803,233 QoQ
Shares Held
144,124
+0.4% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#336
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $708,681,337 across 15 Drug Manufacturers - General names. GILD ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
181,813 | $218,071,984 | |
| 2 | ABBV |
AbbVie Inc.
|
566,381 | $142,524,114 | |
| 3 | JNJ |
Johnson & Johnson
|
486,640 | $123,591,960 | |
| 4 | MRK |
Merck & Co., Inc.
|
469,217 | $60,294,384 | |
| 5 | PFE |
Pfizer Inc
|
1,820,575 | $43,839,446 | |
| 6 | AMGN |
Amgen Inc
|
107,825 | $39,045,589 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
434,411 | $25,030,761 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
144,124 | $18,208,626 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,208,626 | 144,124 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $20,011,859 | 143,588 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $17,222,999 | 140,321 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $17,964,573 | 161,843 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $18,054,736 | 162,846 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $21,376,114 | 190,773 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $14,062,685 | 152,243 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,391,173 | 135,868 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $12,234,741 | 178,323 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $13,010,518 | 177,618 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $17,821,713 | 219,994 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $15,154,366 | 202,220 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $10,608,762 | 137,651 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $11,856,910 | 142,906 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $12,355,703 | 143,922 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $9,963,551 | 161,510 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $9,671,225 | 156,467 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $8,973,858 | 150,948 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $10,842,343 | 149,323 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $10,674,826 | 152,825 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $10,996,942 | 159,700 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $10,340,993 | 160,003 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $9,044,981 | 155,252 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $10,041,396 | 158,908 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $17,538,319 | 227,948 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $19,244,719 | 257,420 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||